UNITED 2.0
Comprehensive tumor profiling (WES + WTS)
Clinical DevelopmentActive
Key Facts
Indication
Comprehensive tumor profiling (WES + WTS)
Phase
Clinical Development
Status
Active
Company
About Lucence Diagnostics
Singapore‑born precision‑diagnostics firm delivering AI‑enhanced liquid‑biopsy and early‑cancer detection tests.
View full company profile